PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Bone Metabolism10.11005/jbm.2021.28.2.1392021282139-150A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial FibrillationDibbendhu Khanra, Anindya Mukherjee, Saurabh Deshpande, Hassan Khan, Sanjeev Kathuria, Danesh Kella, Deepak Padmanabhanhttp://e-jbm.org/upload/pdf/jbm-2021-28-2-139.pdf, http://e-jbm.org/journal/view.php?doi=10.11005/jbm.2021.28.2.139, http://e-jbm.org/upload/pdf/jbm-2021-28-2-139.pdf
Frontiers in Cardiovascular Medicine10.3389/fcvm.2021.71318720218Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-AnalysisXiaojuan Wu, Linyan Hu, Jinjin Liu, Qiuping Guhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.713187/full
Age and Ageing10.1093/ageing/afy135.01201847suppl_3iii28-iii3076DEVELOPING A PROTOCOL FOR A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES COMPARING DIRECT ORAL ANTICOAGULANTS WITH VITAMIN K ANTAGONISTS FOR STROKE PREVENTION IN PEOPLE AGED OVER 75 WITH ATRIAL FIBRILLATIONA Mitchell, M C Watson, T Welsh, A McGroganhttp://academic.oup.com/ageing/article-pdf/47/suppl_3/iii28/25713994/afy135.01.pdf
European Heart Journal10.1093/ehjci/ehaa946.3378202041Supplement_2Meta-analysis comparing the efficacy and safety of direct acting oral anticoagulants to warfarin in patients with atrial fibrillation with and without diabetesS Shetty, H Malikhttp://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3378/34520739/ehaa946.3378.pdf, http://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.3378/34520739/ehaa946.3378.pdf
EP Europace10.1093/europace/euab116.268202123Supplement_3Non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in (morbidly) obese or low body weight patients with atrial fibrillation: a meta-analysisM Grymonprez, TL De Backer, S Steurbaut, K Boussery, L Lahoussehttp://academic.oup.com/europace/article-pdf/23/Supplement_3/euab116.268/38131217/euab116.268.pdf, http://academic.oup.com/europace/article-pdf/23/Supplement_3/euab116.268/38131217/euab116.268.pdf
Global Heart10.1016/j.gheart.2016.03.0482016112e14-e15OC11_02 Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial FibrillationS. Wu, Y.M. Yanghttps://api.elsevier.com/content/article/PII:S2211816016300485?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S2211816016300485?httpAccept=text/xml
Revista Española de Cardiología (English Edition)10.1016/j.rec.2018.03.0092019724305-316Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysisCarlos Escobar, Julio Martí-Almor, Alejandro Pérez Cabeza, M. José Martínez-Zapatahttps://api.elsevier.com/content/article/PII:S1885585718300938?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1885585718300938?httpAccept=text/plain
The Journal of Thoracic and Cardiovascular Surgery10.1016/j.jtcvs.2021.07.0342021Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: A meta-analysisYujiro Yokoyama, Alexandros Briasoulis, Hiroki Ueyama, Makoto Mori, Masao Iwagami, Naoki Misumida, Hisato Takagi, Toshiki Kunohttps://api.elsevier.com/content/article/PII:S0022522321011338?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022522321011338?httpAccept=text/plain
The American Journal of Cardiology10.1016/j.amjcard.2020.03.048202012623-28Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial FibrillationKazuhiko Kido, Mikiko Shimizu, Tsuyoshi Shiga, Masayuki Hashiguchihttps://api.elsevier.com/content/article/PII:S0002914920303374?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0002914920303374?httpAccept=text/plain
European Heart Journal10.1093/eurheartj/ehz745.1133201940Supplement_1P4757Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort studyC Binding, J B Olesen, B Abrahamsen, L Staerk, G Gislason, A N Bondehttp://academic.oup.com/eurheartj/article-pdf/40/Supplement_1/ehz745.1133/30202199/ehz745.1133.pdf, http://academic.oup.com/eurheartj/article-pdf/40/Supplement_1/ehz745.1133/30202199/ehz745.1133.pdf